AbioMed
Sign in to saveAbiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo.
OverviewAI-generated
AbioMed is a company and funder established in 1981. It is an operating entity incorporated in Delaware and located in Danvers, United States. The organization operates within the industry of Surgical & Medical Instruments & Apparatus.
The company is recognized in the Sp 500 collection. It holds the Central Index Key 0000815094 and the Standard Industrial Classification code 3841. Its fiscal year ends on March 31. AbioMed has filed the SC 13G/A form, with a latest filing date of January 6, 2023.
Synthesized by Vinony from 24 facts across 5 sources: Wikidata, Firecrawl, SEC EDGAR, ROR, Vinony collections. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Company
- Industry
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Entity type
- operating
- Fiscal year end
- Mar 31
- Latest filing
- SC 13G/A · 2023-01-06
- Jurisdiction
- US-DE
- Headquarters
- Danvers, US
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1981
- Location
- Danvers, United States
- Status
- Active
GRID grid.281749.1 · ISNI 0000 0004 0415 9035
Described at
ABIOMED INC - Wikirate, an Open ESG Data Platform
wikirate.org →Link to a page describing this subject · 2,687 chars · not written by Vinony
Wikidata facts
- Instance of
- public company
- Part of
- S&P 500
- Country
- United States
- Headquarters
- Danvers
- Parent organization
- Johnson & Johnson
- Stock exchange
- Nasdaq
- Legal form
- Delaware corporation
- Official website
- www.abiomed.com
Show 2 more facts
- inception
- 1981-00-00
- described at URL
- wikirate.org/ABIOMED_INC
via Wikidata · CC0
~9 min read
Encyclopedic overview
6 sectionsContents
- History
- Technology
- Leadership
- See also
- References
- External links
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo.
Andrew Greenfield is President of the company, with Dr. Thorsten Siess as Executive Vice President and Chief Technology Officer and Dr. Chuck Simonton as Executive Vice President and Chief Medical Officer. According to Bloomberg, the company "engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients".
Excerpted from Wikipedia’s “AbioMed” article, available under the CC BY-SA 4.0 licence.